Fireside Chat with bluebird bio: COVID-19 Impact On Regulatory Teams

Scott Cleve, VP of Regulatory Operations & Compliance at bluebird bio, discusses the following questions and more:

• How did bluebird manage the rapid transition to remote work?
• What changes have there been in interactions with FDA and other health authorities?
• From a regulatory technology standpoint, what changes were needed to facilitate remote working?
• In the new virtual world, how do you see inspection readiness changing?

You can also see the results from the study Scott references, Gens & Assoc. COVID-19 Regulatory Impact, here.